WR99210

Research use only, not for human use.

WR99210 is effective against the most pyrimethamine-resistant Plasmodium falciparum strains.

WR99210 is effective against the most pyrimethamine-resistant Plasmodium falciparum strains. WR99210 is an effective inhibitor of dihydrofolate reductase (IC50:<0.075 nM).

WR99210 (0-100 nM; 92 h) is highly effective against T. gondii tachyzoites in tissue culture.WR99210 (0-100 nM; 92 h) shows low cytotoxicity to human foreskin fibroblasts.Cell Viability Assay Cell Line:Human foreskin fibroblasts (T. gondii-infected)Concentration:0-100 nM Incubation Time:92 h Result:Showed marked inhibition of T. gondii, with an IC50 value of approximately 50 nM.Cell Cytotoxicity Assay Cell Line:Human foreskin fibroblasts Concentration:0-100 nM Incubation Time:92 h Result:Lacked of toxicity for fibroblasts.

WR99210 (1.25 mg/kg; i.p.; single daily for 5 days) is highly effective against T. gondii tachyzoites in a mouse model. Animal Model:Male mice (T. gondii-infected).Dosage:1.25 mg/kg Administration:Intraperitoneal injection; single daily for 5 days.Result:Exhibited intraperitoneal parasite numbers were 2 logs less in mice on the day 5.

——

Cell Cycle/DNA Damage

DHFR

DHFR

——

——

47326-86-3

394.68

C14H18Cl3N5O2

>98% (HPLC)

DMSO : 5 mg/mL (12.67 mM; Need ultrasonic)

CC1(N=C(N=C(N1OCCCOC2=C(C=C(C(Cl)=C2)Cl)Cl)N)N)C

——

(-20℃)

With Ice Pack

≥ 2 years